Wei Shi

Nanjing University of Chinese Medicine — China

Environmental Science · Physical Sciences

19h-index2.1kcitations62works5.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Effects and risks of endocrine disrupting chemicals(13), Computational Drug Discovery Methods(10), Gastric Cancer Management and Outcomes(9), Gastrointestinal Tumor Research and Treatment(9), Pharmaceutical and Antibiotic Environmental Impacts(7)

Publications62 total

Obesity and Its Comorbidities: Current Treatment Options, Emerging Biological Mechanisms, Future Perspectives and Challenges
Diabetes Metabolic Syndrome and Obesity·2025· 6 citedOpen Access
Supplementary Figure 3 from First-Line Apatinib Combined with Tislelizumab and Chemotherapy for Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma with Poor Prognosis
2025Open Access
Supplementary Figure 6 from First-Line Apatinib Combined with Tislelizumab and Chemotherapy for Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma with Poor Prognosis
2025Open Access
Supplementary Figure 2 from First-Line Apatinib Combined with Tislelizumab and Chemotherapy for Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma with Poor Prognosis
2025Open Access
Data from First-Line Apatinib Combined with Tislelizumab and Chemotherapy for Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma with Poor Prognosis
2025Open Access
Supplementary Figure 1 from First-Line Apatinib Combined with Tislelizumab and Chemotherapy for Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma with Poor Prognosis
2025Open Access
Supplementary Data from First-Line Apatinib Combined with Tislelizumab and Chemotherapy for Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma with Poor Prognosis
2025Open Access
Supplementary Figure 5 from First-Line Apatinib Combined with Tislelizumab and Chemotherapy for Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma with Poor Prognosis
2025Open Access
Supplementary Figure 4 from First-Line Apatinib Combined with Tislelizumab and Chemotherapy for Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma with Poor Prognosis
2025Open Access
Deciphering the Microbiome-Gut-Eye Axis: A Mendelian Randomization Analysis of the Causal Influence of Gut Microbiota on Myopia
Combinatorial Chemistry & High Throughput Screening·2025· 1 citedOpen Access
First-Line Apatinib Combined with Tislelizumab and Chemotherapy for Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma with Poor Prognosis
Molecular Cancer Therapeutics·2025
Critical Structures of Bisphenol Analogues on Embryonic Toxicity Identified by a Computational Approach
Environmental Science & Technology·2025· 3 cited
Strongly coordinating mediator enables single-step resource recovery from heavy metal-organic complexes in wastewater
Nature Communications·2024· 28 citedOpen Access
Estro-Androgenic Disrupting Effects of Halogenated Disinfection Byproducts: A Comprehensive Evaluation and Comparison
Environmental Science & Technology·2024· 4 cited
Advancing the Effect-Directed Identification in Combined Pollution: Using Pathways to Link Effects and Toxicants
Environmental Science & Technology·2024· 7 cited
Identification of Key Toxic Substances Considering Metabolic Activation: A Combination of Transcriptome and Nontarget Analysis
Environmental Science & Technology·2024· 3 cited
High-Efficiency Effect-Directed Analysis Leveraging Five High Level Advancements: A Critical Review
Environmental Science & Technology·2024· 24 cited
Identify organic contaminants of high-concern based on non-targeted toxicity testing and non-targeted LC-HRMS analysis in tap water and source water along the Yangtze River
Water Research·2024· 21 cited
Are New Phthalate Ester Substitutes Safer than Traditional DBP and DiBP? Comparative Endocrine-Disrupting Analyses on Zebrafish Using <i>In Vivo</i>, Transcriptome, and <i>In Silico</i> Approaches
Environmental Science & Technology·2023· 40 cited
QSAR tools for toxicity prediction in risk assessment—Comparative analysis
Elsevier eBooks·2023· 5 cited
page 1 of 4Next →

Frequent Co-authors

Xiaowei Zhang(16), Hongxia Yu(15), Haoyue Tan(11), Jing Guo(9), Pu Xia(7), Si Wei(7), Qinchang Chen(4), Shaoqing Zhang(4), Qing Zhou(4), Maoyong Song(3), Zhiwei Wang(3), Xiao Gou(3), Yanhong Shen(3), Chang Wang(3), Liben Chou(3), Keng Tu(3), Guibin Jiang(2), Paul B. Yu(2), Fei Gao(2), Xuesong Li(2)